Robeco Institutional Asset Management B.V. Sells 454,702 Shares of The Clorox Company $CLX

Robeco Institutional Asset Management B.V. lessened its holdings in The Clorox Company (NYSE:CLX) by 42.0% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 629,021 shares of the company’s stock after selling 454,702 shares during the period. Robeco Institutional Asset Management B.V. owned 0.52% of Clorox worth $77,558,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after acquiring an additional 514 shares during the last quarter. Nissay Asset Management Corp Japan ADV raised its stake in Clorox by 1.3% in the first quarter. Nissay Asset Management Corp Japan ADV now owns 15,907 shares of the company’s stock valued at $2,342,000 after purchasing an additional 205 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Clorox by 147.6% in the first quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock valued at $104,107,000 after purchasing an additional 421,453 shares in the last quarter. Ashton Thomas Private Wealth LLC lifted its position in Clorox by 33.9% during the first quarter. Ashton Thomas Private Wealth LLC now owns 9,688 shares of the company’s stock valued at $1,427,000 after purchasing an additional 2,454 shares during the last quarter. Finally, Voleon Capital Management LP purchased a new position in Clorox in the 1st quarter worth approximately $375,000. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.6%

NYSE CLX opened at $100.68 on Wednesday. The firm has a market cap of $12.28 billion, a PE ratio of 15.81, a price-to-earnings-growth ratio of 0.50 and a beta of 0.58. The Clorox Company has a 1-year low of $96.66 and a 1-year high of $164.22. The stock has a 50-day moving average of $103.47 and a 200-day moving average of $115.96. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.Clorox’s revenue for the quarter was down 18.9% compared to the same quarter last year. During the same period last year, the company earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio is currently 77.86%.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of research analyst reports. TD Cowen dropped their price objective on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. The Goldman Sachs Group cut their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. UBS Group set a $119.00 price objective on Clorox and gave the company a “neutral” rating in a report on Tuesday, November 4th. Finally, BNP Paribas Exane dropped their target price on Clorox from $110.00 to $103.00 and set an “underperform” rating for the company in a research report on Tuesday, November 4th. One equities research analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $124.44.

Insiders Place Their Bets

In other news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The shares were acquired at an average price of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.63% of the stock is owned by insiders.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.